GlassScriptPhysician profile
Julia M Willingham
NPI 1154765147
$8,815.53
in general payments reported to CMS, 2019-2025
42 companies · $2,193 in 2025
The $2,193 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $902 · 2020: $186 · 2021: $806 · 2022: $404 · 2023: $2,383 · 2024: $1,941 · 2025: $2,193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,684 · Travel and Lodging: $1,574 · Honoraria: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,684.30 |
| Travel and Lodging | $1,574.33 |
| Honoraria | $257.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,652.51 | 2019-2025 | Moses 550 D\F\L, Bulkamid, Rezum Generator |
| Axonics, INC. | $961.81 | 2021-2024 | Axonics, Bulkamid |
| Teleflex LLC | $770.17 | 2021-2025 | Barrigel, Urolift |
| Calyxo, INC. | $572.99 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $371.91 | 2019-2024 | Xtandi |
| Olympus America INC. | $350.81 | 2020-2025 | Itind System |
| Bluewind Medical | $332.60 | 2024-2025 | Revi |
| Abbvie INC. | $292.97 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $264.99 | 2024-2025 | Gemtesa, Orgovyx |
| Procept Biorobotics Corporation | $242.48 | 2025 | |
| 180 Medical, INC. | $236.12 | 2021-2025 | Gentlecath Glide |
| Urogen Pharma, INC. | $226.69 | 2024-2025 | |
| Valencia Technologies Corporation | $176.51 | 2025 | Ecoin Device Kit |
| Coloplast Corp | $123.18 | 2023-2025 | Luja Coude |
| Ferring Pharmaceuticals INC. | $106.21 | 2025 | Adstiladrin |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $93.20 | 2019-2022 | |
| Endo USA, INC. | $87.90 | 2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $77.19 | 2024-2025 | Keytruda, Keytruda Qlex |
| Myovant Sciences INC. | $75.32 | 2022 | |
| Neotract INC. | $65.56 | 2019-2020 | |
| Janssen Biotech, INC. | $65.18 | 2019-2025 | Erleada |
| Immunitybio, INC. | $54.70 | 2025 | |
| Allergan, INC. | $51.94 | 2019-2022 | |
| Tolmar, INC. | $48.82 | 2024-2025 | Jatenzo, Eligard |
| Bioprotect Medical, INC. | $47.48 | 2024-2025 | Bioprotect Balloon Implant System |
| Travere Therapeutics, INC. | $46.43 | 2019 | |
| Medtronic USA, INC. | $42.86 | 2019 | |
| Antares Pharma, INC. | $40.87 | 2019-2025 | Xyosted |
| Laborie Medical Technologies Corp. | $39.03 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Genzyme Corporation | $36.62 | 2019 | |
| Blue Earth Diagnostics | $33.89 | 2019 | |
| Cook Medical LLC | $28.92 | 2024 | Resonance |
| Telix Pharmaceuticals | $27.47 | 2025 | Illuccix |
| Bayer Healthcare Pharmaceuticals INC. | $22.70 | 2024 | |
| Azurity Pharmaceuticals, INC. | $22.23 | 2025 | Azmiro |
| Ambu INC. | $21.87 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $19.99 | 2025 | Exparel |
| Civco Medical Instruments | $19.27 | 2025 | |
| Accord Healthcare, INC. | $18.79 | 2022 | |
| Medtronic, INC. | $18.54 | 2022 | |
| Urovant Sciences INC | $15.16 | 2022 | |
| Mission Pharmacal Company | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Willingham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.